US Export Plan - Sector Report - HealthTech & Digital Health

Industry trends

Healthcare systems across the world are undergoing huge transformation through the increasing use of artificial intelligence (AI), which is expected to revolutionise patient care, streamline operations and drive innovation. Scotland is taking a key position in this space, thanks to its work in bringing together high-quality national data assets, enabling the optimised use of resources and predictive analysis, to enhance service delivery and transform healthcare outcomes. This pioneering approach to data and AI in healthcare has garnered global recognition as a benchmark for quality in digital health transformation.^[6]

Looking ahead, Scotland’s emphasis on data-driven decision-making in healthcare illustrates a broader trend toward the integration of data and artificial intelligence in health and social care systems. As these technologies continue to evolve, their role in shaping long-term service delivery, improving efficiency, and supporting preventative care is expected to expand. Scotland’s approach highlights how evidence-based methods can inform sustainable health strategies, offering insights into how data and AI may underpin future models of care across different contexts. Many of the lessons learned and technologies developed in Scotland can be adapted to other markets, and Scotland’s trailblazing is expected to increasingly open more opportunities for exports in the sector.

The use of AI in HealthTech and digital health is prevalent in the US as well. The US AI medical diagnostics market alone is expected to be worth $790 million in 2025, and is forecast to grow to $4.29 billion by 2034.^[7] AI diagnostic technologies related to neurological diseases are being actively developed in the US, and the application of AI in radiology is also spreading rapidly. The trend towards the use of AI medical diagnostics by major US hospitals and research organisations is particularly driven by the importance of incidental findings and opportunistic screening in early disease detection. Organisations like the US Preventive Services Task Force and the American College of Radiology have been working on applying AI in other areas, such as lung cancer screenings, and defining best practice for AI-assisted interpretation.

Another defining trend in the HealthTech and digital health sector is the growing recognition of the challenges in hospital-centric care models, particularly as populations age and demand for healthcare services continues to rise. Increasingly, the focus is shifting toward remote monitoring technologies, enabling treatment at home through digital health platforms, and AI-driven decision support tools. By embedding innovation into everyday healthcare pathways, whether through wearable sensors, telemedicine, or personalised digital therapeutics, HealthTech is reshaping the future of healthcare delivery, ensuring that hospitals are reserved for the most critical interventions while more routine and preventive care is managed in the community.^[8] The US is also seeing this shift away from hospital-focused care and towards decentralised, tech-enabled healthcare delivery. Remote patient monitoring (RPM) and home-based care have seen significant adoption, with nearly 50 million Americans using RPM devices and Medicare processing over 13 million RPM-related claims between 2019 and 2023. The RPM market is expanding rapidly with industry analyses estimating that the US RPM market was valued around $14-15 billion in 2024 and will double to over $29 billion by 2030 (roughly 12-13% CAGR).^[9] This trend is reinforced by the growth of the home healthcare market, projected to reach $107 billion in 2025, driven by aging demographics and patient preference for “aging in place.”